Celsius Holdings Inc CELH shares are trading lower Monday. Roth MKM lowered its price target from $96 to $87.
What Happened: Roth MKM analyst Sean McGowan maintained Celsius Holdings with a Buy rating on Monday, but cut the firm’s price target from $96 to $87.
The price target change follows several downward analyst revisions from last week, citing an inventory reduction from PepsiCo Inc PEP.
Here’s a look at all of the analyst updates from last week:
- Morgan Stanley analyst Eric Serotta maintained Celsius with an Equal-Weight and lowered the price target from $75 to $68.
- Stifel analyst Mark Astrachan maintained Celsius with a Buy and lowered the price target from $95 to $85.
- Wedbush analyst Gerald Pascarelli maintained Celsius with an Outperform and lowered the price target from $85 to $83.
- Jefferies analyst Kaumil Gajrawala maintained Celsius with a Buy and lowered the price target from $104 to $98.
- TD Cowen analyst Vivien Azer maintained Celsius with a Buy and lowered the price target from $95 to $85.
CEO John Fieldly and CFO Jarrod Langhans participated in a fireside chat at the annual Evercore ISI Consumer and Retail Conference last week.
How To Buy CELH Stock
Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, in Celsius Holdings' case, it is in the Consumer Staples sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
CELH Price Action: Celsius shares were down 3.49% at $57.76 at the time of publication, according to Benzinga Pro.
Photo: Shutterstock.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.